Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers

PURPOSE: (18)F-fluorodeoxyglucose positron emission tomopraphy/computed tomography (FDGPET/CT) has been proven to be useful for imaging many types of cancer; however, its role is not well defined in hepatocellular carcinoma (HCC). We assessed the prognostic value of metabolic imaging biomarkers as e...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Nucl Med Mol Imaging
Prif Awduron: Takeuchi, Satoshi, Rohren, Eric M., Abdel-Wahab, Reham, Xiao, Lianchun, Morris, Jeffrey S., Macapinlac, Homer A., Hassan, Manal M., Kaseb, Ahmed O.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5400685/
https://ncbi.nlm.nih.gov/pubmed/27942837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3583-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg